Pharmaceuticals

NRx Receives FDA Response Regarding Ketamine Study for Suicidal Depression in Youth

bexib
By bexib 0 Min Read

The company said it would conduct an investigation based on the agency’s guidance.

You Might Also Like

As the Senate turns its attention to patents, a former director of the U.S. Patent and Trademark Office is calling the effort a “big misunderstanding.”

Illumina Advances Genomic Sequencing in Oncology at ASCO

FDA approves Voquezna for GERD treatment

Arizona oncology chief says AI could help solve cancer’s ‘ZIP code lottery’ as health disparities persist

Congress should conduct a more careful and bipartisan pandemic postmortem

Share This Article
Previous Article Senator Cynthia Lummis unveils bill for US to buy 1 million Bitcoin
Next Article Maldives Launches ‘Welcome India’ Roadshow Series in India – Hotelier Maldives
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Revolut launches robo-advisor in Singapore
Fintech
This hurricane season, do your customers know the difference between homeowners insurance and flood insurance?
Insurance
Crypto.com launches US institutional exchange
Fintech
Trafalgar St James unveils Rockwell Bistro & Wine Bar; first phase of hotel’s £6m refurbishment
Hospitality & Tourism